Abstract:Abstract Abstract 3853 B-cell differentiation is tightly regulated by synchronized suppression and/or induction of specific transcription factors. Among them, B-cell lymphoma 6 (BCL6) and PRDM1 are considered to be master regulators for germinal center formation and terminal B-cell differentiation. Dysregulation of BCL6 and PRDM1 also have been associated with lymphomagenesis. Their regulation still need further study especially at the posttranscriptional level. Here, by using co-culture system and whole genomic microRNA microarray profiling, we show for the first time that direct B lymphoma cell-stroma cell contact between follicular dendritic cells and B-lymphocytes could induce upregulation of miR-30 family and downregulation of miR-9 and let-7 family. In silico analysis showed that miR-30s can target genes BCL6 and miR-9/let7 can target PRDM1 with direct binding sites in 3`UTR region of their mRNAs. The microarray data can be proved by microRNA specific Q-RT-PCR. Specifically, by both gain of function and loss of function studies, we functionally verified that FDCs Regulate Expression of BCL6 and PRDM1 via Cell-Cell Direct Contact induced correlated microRNA dysregulation. To further validate the direct interaction between BCL6 and miR-30, we constructed luciferase reporters containing the BCL6 3`-UTR that included miR-30 binding sites and a mutant 3`-UTR harboring mutations in the “seed pairing” sequences of the miR-30 binding site. Co-transfection of miR-30 and reporter construct into cells significantly decreased luciferase activity in wild-type but not in mutant BCL6-3`-UTR transfected cells, supporting the role of miR-30 family in the regulation of BCL6 expression. BCL6 and PRDM1 and their regulation miRNAs, let-7 and miR-30, also can be validated in primary normal B-lymphocytes and lymphoma cells by using our co-culture system. Dysregulation of BCL6 and PRDM1 is often associated with lymphomagenesis. We firstly identified that BCL6 is the direct target of miR-30 family and also verified PRDM1 is the target of miR-9, and let-7 in our system. Our studies provide a novel mechanism of post-transcriptional regulation of BCL6 and PRDM1 by several microRNAs. In the context of micro-environment, it provides a clue for germinal center B-cell differentiation as well as B-cell lymphomas progression regulated by lymphocyte cell-stroma cell contact through microRNAs. Disclosures: No relevant conflicts of interest to declare.

Advance of the relationship between PRDM1 and lymphomas

Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis

PRDM1 expression and prognostic value in patients with diffuse large B-cell lymphoma

Prdm1 Is Involved In Chemoresistance Of T-Cell Lymphoma And Down-Regulated By The Proteasome Inhibitor

Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.

The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma: A retrospective cohort study in China

Follicular Dendritic Cell-Induced Microrna-Mediated Upregulation of Prdm1 and Downregulation of Bcl-6 in Non-Hodgkin'S B-Cell Lymphomas

Loss of Promoter Methylation Contributes to the Expression of Functionally Impaired PRDM1β Isoform in Diffuse Large B-cell Lymphoma

Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogenetics

PRDM1 Levels Are Associated with Clinical Diseases in Chronic HBV Infection and Survival of Patients with HBV-related Hepatocellular Carcinoma

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

Clinical significance of PRDM1 gene expression in laryngeal squamous cell carcinoma

Microenvironment-Mediated Regulation of Micrornas in B-Lymphocytes As a Novel Mechanism for Terminal B-Cell Differentiation and Lymphomagenesis.

Follicular Dendritic Cell (Fdc)-Induced Microrna-Mediated Up-Regulation of PRDM1 and Down-Regulation of BCL6 in Germinal Center B Lymphocytes: A Potential Mechanism for B-Cell Differentiation.

PRDM1 Rs1010273 Polymorphism is Associated with Overall Survival of Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.

The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type

[Research Progress on B Lymphocyte-Induced Maturation Protein 1 and Its Relationship with the Development of Lymphoma].

PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells

Unravelling the function of prdm16 in human tumours: A comparative analysis of haematologic and solid tumours

PRDM16 Induces Methylation of FLT3 to Promote FLT3-ITD Signaling and Leukemia Progression

High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer